Do we all still feel good about end of year targets? I'm worried I might be a little high.
But that never stopped me.
But that never stopped me.
GBA Presents: RADIO SAVANT-!
- Thread starter stonedinvestor
- Start date
Futures turnover. Didn't like the headline inflation number.
And what the hell with energy? I can't get that right.
And what the hell with energy? I can't get that right.
Who do the Giants play this week?
Odds?
3961 If we can hold this/// Yesterday Mid day level....
Lizard King will maintain his position.
Lizard King will maintain his position.
Boy Van we have the toughest match up ever. The best team in the NFL- The Eagles.
I have been spending alot of time hand holding and yelling at the fans over at BBWC.
I really think we can upset the Eagles.
Sempra (SRE)- I think a wise idea here. But energy has been all over the place really dipping and I'm not sure why. China re open story did not seem to boost oil.
NYSE - NYSE Delayed Price.
SRE @ 162
NYSE - NYSE Delayed Price.
SRE @ 162
Ohhh, ok.
Earlier this week I had Cramer dvr'd and I watched his interview with a ceo out of GA. The guy said something about Go Bulldogs, and Cramer said, since the conversation had turned to football, something about "as long as the Giants lose".
I thought it was another jab at you.
It was. Cramer is a huge Eagles fan. Kind of sums up the man doesn't it?
ANALYST UPGRADE OF THE DAY - THIS TOOK SOME BALLS--
BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential 08:12 CS BofA analyst Alastair Ryan upgraded Credit Suisse to Buy from Neutral with a CHF 3.60 price target, noting that his new target suggests more than 20% upside potential. While he sees the rebuild of Credit Suisse "taking time," he notes that the bank's CHF 12B market cap is the same as Julius Baer's despite Credit Suisse being one-and-a-half times larger in wealth management and also having a leading domestic bank and asset management business. With Europe's "lowest price/book," he sees the shares trading at an "attractive" level, the analyst said.
I have been very worried about this name. My son's ex-girlfriend (the one who's father stepped off the roof) her Mom works at CS. I have been very nervous about her job security.
ANALYST UPGRADE OF THE DAY - THIS TOOK SOME BALLS--
BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential 08:12 CS BofA analyst Alastair Ryan upgraded Credit Suisse to Buy from Neutral with a CHF 3.60 price target, noting that his new target suggests more than 20% upside potential. While he sees the rebuild of Credit Suisse "taking time," he notes that the bank's CHF 12B market cap is the same as Julius Baer's despite Credit Suisse being one-and-a-half times larger in wealth management and also having a leading domestic bank and asset management business. With Europe's "lowest price/book," he sees the shares trading at an "attractive" level, the analyst said.
I have been very worried about this name. My son's ex-girlfriend (the one who's father stepped off the roof) her Mom works at CS. I have been very nervous about her job security.
In September 2022, Blue Water Vaccines had US$29m in cash, and was debt-free. Importantly, its cash burn was US$6.6m over the trailing twelve months. That means it had a cash runway of about 4.4 years////
The question is did they tap into that $29 mil for this--> Nov 20th
Blue Water Vaccines Inc (NASDAQ: BWV) has signed an exclusive, global license agreement for a live attenuated, oral Chlamydia vaccine candidate from The University of Texas Health San Antonio.
- According to the CDC, Chlamydia is the most frequently reported bacterial STI in the U.S, with about 1.6 million new cases reported in 2020 alone.
- Globally, the WHO estimates about 129 million new cases of chlamydia each year. This may be an underrepresentation given that many cases are asymptomatic and the low availability of diagnostic testing in low- and middle-income countries.
- Currently, no vaccine is available to prevent chlamydia infection, and the primary treatment is through antibiotic regimens with the possibility of reinfection after antibiotics have treated the disease.
- If undetected or left untreated, chlamydia represents a significant cause of pelvic inflammatory disease and infertility in women.
- Price Action: BWV shares are up 21% to $1.38 on the last check Monday.